Yes, patients with sensory processing difficulties can generally take bupropion (Wellbutrin), as there are no absolute contraindications related to sensory issues.
Bupropion can be prescribed to patients with sensory processing difficulties, though clinicians should monitor for rare sensory adverse effects and consider the patient's specific clinical context.
Key Considerations
Established Contraindications (None Related to Sensory Issues)
The FDA-approved contraindications for bupropion do not include sensory processing disorders 1. Absolute contraindications are:
- Seizure disorder
- Current or prior bulimia/anorexia nervosa
- Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs
- Concurrent MAOI use (within 14 days)
- Known hypersensitivity to bupropion
Rare Sensory Adverse Effects to Monitor
While sensory issues are not contraindications, isolated case reports document uncommon sensory adverse effects:
Auditory effects:
- Tinnitus (bilateral, low-pitched humming) has been reported after dose escalation to 300 mg/day, which resolved completely upon discontinuation 2
- One case reported tinnitus as part of a symptom cluster mimicking transient ischemic attack 3
Neurological sensory effects:
- One case documented isolated impairment of sensory trigeminal nerve function (circumscribed unilateral numbness) that resolved after discontinuation 4
- Paresthesia has been reported in combination with other neurological symptoms 3
Motor manifestations:
- New-onset tic disorder (motor and vocal tics) has been exceptionally rarely reported, resolving upon discontinuation 5
Clinical Decision Algorithm
For patients with pre-existing sensory processing difficulties:
Assess seizure risk factors - This is the primary safety concern, not sensory issues 6
Consider potential benefits - Bupropion may be particularly appropriate for patients with:
Initiate with standard dosing:
- Start 150 mg once daily for 3 days
- Increase to 150 mg twice daily if tolerated
- Maximum 300 mg/day 7
Monitor specifically for:
Discontinue immediately if:
- Seizure occurs
- Severe sensory symptoms develop
- Neuropsychiatric adverse events emerge
Important Clinical Context
The 2022 AGA guidelines conditionally recommend naltrexone-bupropion ER for obesity management, noting that bupropion should be "avoided in patients with seizure disorders and used with caution in patients at risk of seizures" 6. The primary safety monitoring focuses on seizure risk, blood pressure, heart rate, and neuropsychiatric symptoms—not sensory processing issues.
The 2016 NCCN smoking cessation guidelines note that neuropsychiatric adverse events with bupropion were not significantly increased compared to placebo in a large multicenter RCT of over 8,000 patients 7. This suggests the overall safety profile is favorable.
Common Pitfall to Avoid
Do not confuse "sensory processing difficulties" (a neurodevelopmental pattern) with the absolute contraindications for bupropion. The documented sensory adverse effects are exceedingly rare case reports 2, 4, 3 and should not prevent appropriate prescribing when clinically indicated. The focus should remain on established contraindications: seizure disorders, eating disorders, and substance withdrawal states 1.